Log In
BCIQ
Print this Print this
 

TauPro (PTI-51-CH3)

  Manage Alerts
Collapse Summary General Information
Company ProteoTech Inc.
DescriptionTau aggregate inhibitors
Molecular Target Microtubule-associated protein tau (tau) (MAPT) (FTDP-17)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentDiscovery
Standard IndicationProgressive supranuclear palsy (PSP)
Indication DetailsTreat progressive supranuclear palsy (PSP)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today